Symbol: |
ZBTB45
|
Description: |
zinc finger and BTB domain containing 45 [Source:HGNC Symbol;Acc:23715]
|
Location: |
Chr19:59024899-59030921[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:246
Gene |
Compound |
Gen_sig |
Exp_pattern |
ZBTB45 |
NSC 105348 |
0.041 |
Up |
ZBTB45 |
NSC 106723 |
0.023 |
Down |
ZBTB45 |
NSC 11865 |
0.017 |
Down |
ZBTB45 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.018 |
Down |
ZBTB45 |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.016 |
Down |
ZBTB45 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.013 |
Down |
ZBTB45 |
STEPHISOFERULINE |
0.004 |
Down |
ZBTB45 |
NSC 135371 |
0.002 |
Down |
ZBTB45 |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.016 |
Down |
ZBTB45 |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.01 |
Down |
ZBTB45 |
NSC 147358 |
0.014 |
Down |
ZBTB45 |
NSC 164887 |
0.041 |
Down |
ZBTB45 |
Bromocriptine methanesulfonate |
0.007 |
Down |
ZBTB45 |
7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- |
0.044 |
Down |
ZBTB45 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.007 |
Down |
Expression pattern: Sensitivity / Resistance
Total:17 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:2
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:50
Total:4 Current:1
[First] [Prev]  Next Last 
|